A detailed history of Envestnet Portfolio Solutions, Inc. transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Envestnet Portfolio Solutions, Inc. holds 1,631 shares of BIO stock, worth $540,986. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,631
Previous 1,624 0.43%
Holding current value
$540,986
Previous $561,000 20.68%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 16, 2024

BUY
$268.26 - $339.48 $1,877 - $2,376
7 Added 0.43%
1,631 $445,000
Q1 2024

May 06, 2024

SELL
$304.11 - $351.99 $281,909 - $326,294
-927 Reduced 36.34%
1,624 $561,000
Q4 2023

Feb 07, 2024

SELL
$269.37 - $365.04 $689,317 - $934,137
-2,559 Reduced 50.08%
2,551 $823,000
Q3 2023

Nov 13, 2023

BUY
$350.25 - $422.63 $1.79 Million - $2.16 Million
5,110 New
5,110 $1.83 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.17B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Envestnet Portfolio Solutions, Inc. Portfolio

Follow Envestnet Portfolio Solutions, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Portfolio Solutions, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Portfolio Solutions, Inc. with notifications on news.